Systemic failures in publicly funded disability care rarely appear as isolated incidents. They emerge through repeating patterns of restricted access, excluded decision-makers, delayed intervention, and unmonitored care, often across multiple programs and service settings. AAA documents these patterns to move the conversation beyond individual disputes and toward systemic accountability, transparency and prevention.
Families and legal decision-makers frequently recognize risk long before systems respond. The following red flags are repeatedly associated with later findings of neglect, harm, or rights violations: Denied or restricted access to a loved one in a group home or care setting; exclusion of family members, guardians, or substitute decision-makers from care planning and health discussions; unexplained changes to medication, routines, or programming; delays in assessments following changes in health or mobility; inconsistent or declining supports without written explanation; resistance to documentation; and the use of trespass notices or access restrictions by contracted service providers delivering publicly funded care. These indicators should never be dismissed as administrative or operational matters. They are signals of elevated risk.
Across both regulated and non-regulated care settings, AAA observes recurring patterns that undermine safety and dignity: Families report being barred from access to loved ones or excluded from decision-making despite legal authority; care providers continue receiving public funding while supports, programming, or community inclusion decline; assessments fail to respond to injury, health deterioration, or changes in capacity; and oversight mechanisms rely on provider self-reporting rather than independent verification.
These patterns appear across multiple organizations and jurisdictions, indicating systemic design failures, not isolated misconduct. There are no consistent best practices, training and staff certification(s).
When families are able to document concerns, records often reveal consistent gaps. Delayed or absent disclosure of injuries, incidents, or allegations of harm; lack of transparency regarding physical injury, neglect, psychological abuse, financial exploitation, sexual abuse, or coercive control; absence of timely reporting to families or legal decision-makers; unclear linkage between public funding and services actually delivered; and limited access to service agreements, individual support plans, or care records related to health and community inclusion.
Taken together, documentation shows a system that often records harm after it occurs, rather than intervening to prevent it. AAA exists to consolidate this evidence, identify patterns, and make systemic risk visible.

AAA is developing a structured, evidence-based framework to support transparency and informed decision-making for families considering publicly funded care settings.
This includes:
The intent is not punitive. It is preventive. AAA’s goal is to support informed choice, similar to consumer-protection models, so families can better assess whether a care setting demonstrates transparency, collaboration, and respect for individual and legal rights before a loved one is placed at risk.
Evidence must lead to accountability.
In Spring 2026, AAA intends to advance a public call for Care and Collaboration in publicly funded disability services, informed by documented patterns across care settings. This initiative will focus on enforceable oversight, individual-level funding monitoring, transparent disclosure of incidents and care plans, and recognition of families and legal decision-makers as essential partners in care. Details will be shared as this work develops.
Have a question or want to learn more about Advocates for Access & Accountablity? Contact us today and we will be happy to provide you with more information. We want to hear from you! Share your personal story of how Advocates for Access & Accountablity has impacted your life or the lives of those around you. Your story can inspire others to get involved and make a difference.
The Evidence & Patterns section documents research, public reports and systemic observations related to publicly funded disability care systems.
It is intended to support the analysis presented in AAA blog posts by providing access to the research and policy materials that inform those discussions.
Topics are organized by theme.

Medication oversight is a critical issue in disability care systems. Individuals with developmental disabilities frequently rely on others to manage health decisions making transparency, informed consent, and monitoring essential safeguards. Research has identified several concerns regarding medication practices in institutional and residential care settings.
1. High Rates of Psychotropic Medication Use
Studies examining adults with developmental disabilities in Ontario have identified high rates of psychotropic medication prescribing. In some cases, these medications are prescribed even when a documented psychiatric diagnosis is not present.
2. Medication Used to Manage Behaviour
Researchers have raised concerns that medications may sometimes be used to manage behaviours rather than treat underlying medical or mental health conditions. This practice can occur when alternative supports or behavioural interventions are limited.
3. Polypharmacy and Monitoring Risks
Polypharmacy, the use of multiple medications simultaneously, increases the risk of adverse drug interactions, sedation, and cognitive impairment. These risks are heightened when medications are not regularly reviewed or coordinated across health providers.
4. Institutional Medication Patterns
Data from Canada’s long-term care sector indicates that nearly one in four residents may receive potentially inappropriate antipsychotic medication. While long-term care differs from developmental disability group homes, these findings illustrate broader systemic risks in institutional care settings.
5. Importance of Clinical Safeguards
Canadian clinical guidelines emphasize that psychotropic medications should not be used as a first-line response to behavioural challenges without psychiatric assessment, informed consent, and ongoing monitoring. Collaborative decision-making with families and legal guardians is considered a key safeguard.
Medication decisions affecting vulnerable individuals require informed consent, medical justification, regular review, and transparent communication with guardians or families. Without these safeguards, medication practices can place individuals at risk of harm.
The purpose of highlighting medication oversight within the Evidence & Patterns section is to better understand systemic risks and encourage stronger accountability across publicly funded care systems
Lunsky, Y., Klein-Geltink, J., & Yates, E. (2018).
Psychotropic medication use among adults with developmental disabilities in Ontario.
Canadian Journal of Psychiatry. https://pubmed.ncbi.nlm.nih.gov/28830241/
Ouellette-Kuntz, H., Shooshtari, S., Balogh, R., & Martens, P. (2015). Health care utilization and prescribing patterns for adults with developmental disabilities.
Journal of Applied Research in Intellectual Disabilities. https://onlinelibrary.wiley.com/journal/14683148
Canadian Institute for Health Information. (2026).
Potentially inappropriate use of antipsychotics in long-term care homes.https://www.cihi.ca/en/indicators/potentially-inappropriate-use-of-antipsychotics-in-long-term-care
Surrey Place / Developmental Disabilities Primary Care Initiative. (2018). Canadian guidelines for primary care of adults with developmental disabilities.
https://ddprimarycare.surreyplace.ca
You may wish to share your experience if you have encountered:
You do not need to have all documentation available to submit this form.
Copyright © 2026 Advocates for Access & Accountablity - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.